Your search for "2010" return 13 results.
Évaluation de l’efficacité des autovaccins contre Streptococcus suis administrés aux truies par mesure de la mortalité et de la consommation d’anti... >
Streptococcus suis est une bactérie à l’origine de pertes importantes en élevage.
Ceva finishes first decade of success with strong growth >
2010 results demonstrate global ability to generate sales and earnings
Nomination of David Derain as Global Human Resources Director >
David Derain joins the Ceva Santé Animale Group as Global Human Resources Director and member of the Executive Committee, with effect from 1st February 2016.
Ceva becomes official partner of Vet2011 >
2011 is World Veterinary year, let’s show pride in our profession “Vet for health, Vet for food, Vet for the planet!”.
Jérôme-André Gauthier, new Strategy and Business Development Director >
Jérôme-André Gauthier joins the Executive Committee team at Ceva Santé Animale as the new Strategy and Business Development Director, starting January 1st, 2014.
Stamp Out Sleeping sickness (S.O.S.) initiative highlighted at WHO 3rd International Conference on Neglected Zoonotic >
At the WHO Third International Conference on Neglected Zoonotic Diseases held on November 23/24 2010, Dr. Anthony Mbonye, the Commissioner of Health Services in Uganda praised the SOS initiative as an...
AXA Private Equity provides additional financing to support the development of Ceva >
AXA Private Equity, the leading European diversified private equity firm, announces today that it is providing €100 million of additional financing to support the development of Ceva.
Ceva conducts Global Vaccine Symposium - 2010, October 6-8th >
Do new technologies go with better poultry production and better global health ?
Ceva continues rapid growth in 2011 >
Twin pillar strategy of combining internal and external growth opportunities drives further global expansion
Ceva adopts new logo >
Following the success of its first 10 year plan, Ceva sets out its vision to create value beyond animal health.